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The Wnt family of secreted ligands plays critical roles during embryonic development and tumori-
genesis. Here we show that Kaiso, a dual speciﬁc DNA-binding protein, functions as a bimodal reg-
ulator of canonical Wnt signaling. Loss-of-function analysis of Kaiso abrogated Wnt-mediated
reporter activity and axis duplication, whereas gain-of-function analysis of Kaiso dose-dependently
resulted in synergistic and suppressive effects. Our analyses further suggest Kaiso can regulate TCF/
LEF1-activity for these effects via modulating HDAC1 and b-catenin-complex formation. Our studies
together provide insights into why Kaiso null mice display resistance to intestinal tumors when
crossed onto an ApcMin/+ background.
Stuctured summary:
MINT-6823807: HDAC1 (uniprotkb:Q13547) physically interacts (MI:0218) with beta catenin (uni-
protkb:P35222) by anti tag coimmunoprecipitation (MI:0007)
MINT-6823820: axin (uniprotkb:O15169) physically interacts (MI:0218) with beta catenin (uni-
protkb:P35222) by anti tag coimmunoprecipitation (MI:0007)
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
DNA methylation on CG repeats is important for epigenetic reg-
ulation leading to gene-silencing events. Dysregulation of DNA
methylation is causative for cancers as well as embryonic defects
[1,2]. Kaiso is a methylated DNA binding protein that binds to
methylated diCpG nucleotides through its ﬁrst two zinc ﬁnger
domains, unlike other methylated DNA binding proteins, such as
MBD1, MBD2, MBD4 and MeCP2 [3], which use a so-called methyl
CpG binding domain (MBD). In addition, Kaiso can recognize the
non-methylated DNA sequence (TNGCAGGA) [4,5]. Kaiso was orig-
inally identiﬁed by a yeast-two hybrid screen using an adhesion
protein p120ctn as a bait [6] and the Kaiso protein consists of a
POZ/BTB domain and three zinc ﬁnger domains. Kaiso also interacts
with the insulator protein CTCF and the N-CoR (nuclear receptor
corepressor 1) protein through its POZ/BTB domain [7,8]. Kaiso is
thought to repress target gene expression by recruiting a repressor
complex [8]. However, the expression of rapsyn is positively regu-
lated by Kaiso with d-catenin, suggesting that Kaisomay possess bi-
modal activity with regards to its regulation of gene expression [9].
Interestingly, Kaiso has been shown to function in the Wnt
signaling pathway. Wnt signaling plays key roles in early
development and its dysregulation causes numerous pathologieschemical Societies. Published by E
ai).including cancer formation and osteoporosis [10]. Wnt/b-catenin
signaling, which is also termed canonical Wnt signaling, controls
cell differentiation and cell proliferation [11], whereas the non-
canonical Wnt pathway (Wnt/PCP and Wnt/Ca2+) regulates cell
polarity and cell movement [12,13]. In the canonical Wnt pathway,
the level of b-catenin protein is tightly regulated by a degradation
complex. In the absence of Wnt, b-catenin is phosphorylated by
CKIa and GSK3 on the scaffolding protein Axin, leading to the ubiq-
uitination and degradation of b-catenin via the proteasome path-
way. The tumor suppressor gene adenomatous polyposis coli
(APC) can complex with Axin to promote b-catenin phosphoryla-
tion, thereby enhancing b-catenin degradation. In the presence of
Wnt, Frizzled and co-receptor LRP5/6 form a ternary complex,
recruiting the cytoplasmic factors Dishevelled and Axin to the
plasma membrane. Thus b-catenin is no longer efﬁciently phos-
phorylated, resulting in the cytoplasmic stabilization of b-catenin.
b-catenin subsequently translocates into the nucleus and mediates
activation of Wnt-responsive genes mainly by binding to members
of the transcription factor TCF/LEF family.
One of the putative direct target genes of Kaiso is Xenopus
Wnt11 [14], which regulates dorsal axis formation [15] and con-
vergent extension in the frog embryo [16]. In addition, it has been
demonstrated that Kaiso negatively regulates the Wnt/b-catenin
target genes siamois and matrilysin/MMP7 [17,18]. An additional
connection between Kaiso and the Wnt/b-catenin pathway was
uncovered when the Kaiso binding protein p120ctn was shownlsevier B.V. All rights reserved.
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protein Dishevelled and transcription factor TCF3 [20,21]. In the
Xenopus embryo, Kaiso is expressed maternally and present
throughout early development [22]. Kaiso knockdown via morpho-
lino antisense oligonucleotides (MO) caused gastrulation defects
[14], as well as an apoptotic phenotype when injected into animal
hemisphere at the 1-cell stage [23]. Somewhat surprisingly how-
ever, Kaiso null mice showed no obvious phenotype [24]. However,
when crossed with tumor-susceptible ApcMin/+ mice, which have a
mutation in APC and thus have up-regulated b-catenin signaling,
Kaiso/y ApcMin/+ mice showed less tumors, implying that Kaiso
possess oncogenic activity [24]. Surprisingly, the expression levels
of putative target genes were not signiﬁcantly changed in Kaiso
null mice. The reason for the considerable differences in observed
phenotypes between Kaiso knocked-down Xenopus embryos and
the targeted null mouse phenotype may be that Xenopus appears
to lack a zBTB4 homolog which is also a methylated DNA binding
protein whose speciﬁcity partly overlapped with Kaiso in the
mouse.
Here we examine the effect of Kaiso in Wnt signaling and show
that Kaiso has bimodal activity in Wnt signaling in Xenopus
embryos. Kaiso knockdown by MO resulted in suppression of
Wnt/b-catenin activity. While mild ectopic expression of Kaiso en-
hanced Wnt/b-catenin signaling, moderate and higher expression
of Kaiso inhibited Wnt/b-catenin signaling. Kaiso can decrease
complex formation between b-catenin and HDAC1, implying that
Kaiso may alleviate the negative effects of HDAC1 from the
b-catenin/TCF complex. Furthermore, the positive role of Kaiso in
Wnt/b-catenin signaling can partly explain why Kaiso null mice
develop less tumors on a cancer susceptible background.2. Materials and methods
2.1. Embryo manipulation, RT-PCR and explant assays
RNA was in vitro transcribed using SP6 mMESSAGEmachine
(Ambion). Eggs were obtained from female Xenopus laevis, and em-
bryos were raised in 0.1 MMR buffer (100 mM NaCl, 2 mM KCl,
1 mM MgSO4, 2 mM CaCl2, 5 mM HEPES, 1 mM EDTA, pH 7.8). Em-
bryos were staged according to Nieuwkoop and Faber [25]. Em-
bryos were microinjected with 5 nl per blastomere of in vitro
synthesized RNA synthesized (mMessage mMachine; Applied Bio-
systems) and/or DNA in 3% Ficoll/0.5MMR buffer. For RT-PCR, to-
tal RNA was isolated from Xenopus animal caps or whole embryo
by TRIzol (Invitrogen) according to the manufacturer’s protocol.
PCR primers for Xnr3, siamois and EF-1a were as previously de-
scribed [26].
2.2. Luciferase assay
Twenty picograms of ﬁreﬂy luciferase reporter constructs in
combination with 2 pg of renilla luciferase (renilla-TK: Promega)
per embryo were injected into two blastomeres of VMZ or DMZ
at the 4-cell stage, or animal pole at the 2-cell stage with MO
and/or mRNAs. Luciferase levels were measured from lysates of
three whole embryos in duplicate or triplicate using the Dual Lucif-
erase Assay Kit (Promega).
2.3. Plasmids and oligonucleotides
Xenopus Kaiso cDNA was obtained from Open Biosystems and
human Kaiso cDNA was obtained from OriGene. Both cDNAs were
subcloned into pCS2 using EcoRI and XhoI sites. All morpholino
antisense oligonucleotides were purchased from Gene Tools.
Xenopus Kaiso Morpholino oligonucleotide (xKaiso MO) sequencewas according to Kim et al. [14]. A standard Control Morpholino
oligonucleotide was used as a negative control. To generate xKaiso
MO-resistant construct, we introduced ﬁve mismatched silent
mutations into coding region of xKaiso, substituting ATGGAGA-
CAAAAAAGCTG with ATGGAAACTAAGAAACTT by QuickChange
(Stratagene).
2.4. Cell culture, conditioned medium (CM) and transfection
293T cells were cultured in DMEM containing 10% FBS at 37 C
in 5% CO2. Conditioned media (CM) was prepared by following
‘‘Protocol for the Puriﬁcation of Wnt Proteins” at The Wnt
Homepage (http://www.stanford.edu/~rnusse/assays/W3aPurif.
htm#medium). Cells in a 12-well plate were transfected with Lipo-
fectamine (Invitrogen) according to manufacturers’ instructions.
2.5. Antibodies and immunoprecipitation
Monoclonal antibody for Flag (M2) was from Sigma and Myc
(9E10) was from Millipore. Whole cell lysate was prepared 24 h
post-transfection with lysis buffer (25 mM Tris–HCl [pH 7.4],
137 mM NaCl, 2.68 mM KCl, 0.6% Triton X-100) including protease
inhibitor cocktail (Complete Mini, Roche). Lysates were precipi-
tated with anti-Flag antibody, resolved by 10% SDS–PAGE and blot-
ted with anti-Myc, or anti-Flag antibody.3. Results
3.1. Kaiso regulation in siamois promoter
The siamois gene is a marker for organizer formation and is re-
quired for dorso-ventral patterning. Its promoter contains three
TCF/LEF1 binding sites within 350-bp and one Kaiso consensus
sequence (KCS) centered around 300-bp (Fig. 1a). First, in order
to examine the role of Kaiso in dorso-ventral pattern formation
using siamois as a target-gene read-out, we performed a luciferase
assay harvesting embryos at st. 10.5 after injection of the reporter
gene with 900 bp of the siamois promoter region [27] together
with Xenopus Kaiso morpholino (xKaiso MO) or control MO into
animal poles, dorsal marginal zone (DMZ) or ventral marginal zone
(VMZ). Unexpectedly, we observed that xKaiso MO signiﬁcantly re-
duced siamois promoter activity at the DMZ (Fig. 1b). In addition,
Kaiso knockdown caused inhibition of reporter activity even with
G to T substitution in KCS injected into DMZ (Fig. 1b), indicating
that Kaiso can act as a positive regulator in Wnt/b-catenin signal-
ing independent of its KCS.
3.2. Kaiso in b-catenin signaling
To test whether Kaiso regulates Wnt/b-catenin signaling
through TCF/LEF1 activity, we used the Super8XTOPFlash lucifer-
ase reporter as a read-out [28]. We injected xKaiso MO or control
MO into the animal pole, VMZ or DMZ, and then harvested em-
bryos at st. 11–12. Kaiso knockdown caused severe reduction of
b-catenin activity at the DMZ (Fig. 1c) consistent with the siamois
promoter results. The endogenous b-catenin pathway is activated
within the ventral mesoderm after midblastula transition [29]
when robust zygotic transcription starts. We observed inhibition
of b-catenin signaling by xKaiso MO at the VMZ, which represents
zygotic b-catenin activity. Since these results contradicted
previously published data [17], we re-evaluated the position of
Kaiso in Wnt/b-catenin signaling. We co-injected xKaiso MO with
b-catenin pathway activators. Indeed, not only was Wnt8 or LRP6
activity reduced, but LEF1 activity was also reduced by xKaiso
MO (Fig. 2a). xKaiso knockdown also repressed the activity of dom-
Fig. 1. (a) A schematic ﬁgure of siamois-luc. The promoter region of siamois-luc
contains three TCF binding sites and one Kaiso consensus sequence (KCS).
siamoisGT-luc has a point mutation at KCS. (b) Kaiso knockdown by speciﬁc MO
(xKaiso MO) injection reduced siamois promoter activity. xKaiso MO had similar
effect with siamoisGT-luc. Embryos were harvested at st10.5. (c) xKaiso MO
injected into DMZ and VMZ inhibited b-catenin/TCF activity in a dose dependent
manner. Embryos were harvested at st. 11–12.
Fig. 2. (a) Twenty nanograms of xKaiso MO antagonized Wnt8, LRP6 and LEF1
activity when injected into animal pole at both blastomeres at 2-cell stage. (b)
xKaiso mRNA by itself mildly activated Super8XTOPFlash (lanes 2 and 3). MO-
resistant xKaiso mRNA rescued xKaiso MO partially (lanes 8 and 9) Injection was
done at 2-cell stage into both blastomeres at animal pole. (c) b-Catenin into VMZ
was antagonized by xKaiso MO, which was also rescued by MO-resistant xKaiso
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shown). These data indicate that Kaiso positively modulates b-
catenin signaling at the transcriptional level. Moreover, the effect
of the xKaiso MO was effectively rescued by the co-injection of
xKaiso mRNA which contains ﬁve silent mismatch mutations with
regards to the morpholino-recognition sequence (Fig. 2b), demon-
strating the speciﬁcity of the xKaiso MO. When injected into VMZ,
xKaiso MO resulted in inhibition of b-catenin activity and again
this inhibition was rescued by the MO-resistant mRNA (Fig. 2c).mRNA. Eggs were harvested at st. 10.5.3.3. Kaiso potentiates Wnt/b-catenin signaling
To examine whether ectopic expression of Kaiso can activate
Wnt/b-catenin signaling, we injected xKaiso mRNA with Wnt3a
or Lef1 into animal caps. Reporter activity was increased by co-
injection of xKaiso with Wnt3a or Lef1 (Fig. 3). Moreover, xKaiso
by itself upregulated Super8XTOPFlash activity (Fig. 2b), which is
reciprocal to the knockdown studies suggesting that Kaiso has po-
sitive role in Wnt/b-catenin pathway. The xKaiso mRNA activity
was blocked by DN-TCF3 (data not shown) which lacks a b-catenin
binding domain and acts as a dominant negative [30], implying
that Kaiso cannot substitute for the absence of b-catenin within
the TCF complex. Taken together, these results support a model
in which Kaiso can enhance Wnt/b-catenin signaling. However,
xKaiso mRNA overexpression ventrally was unable to induce axis
duplication (data not shown), suggesting that Kaiso functions as
a modulator in Wnt/b-catenin signaling.3.4. Kaiso positively and negatively regulates b-catenin signalin
Next, we tested whether Kaiso modulates expression of endog-
enous Wnt-target genes. Previously it has been shown that siamois
expression was regulated by TCF and Kaiso [17]. We found that
xKaiso mRNA injection can synergize with Wnt3a for siamois
induction using animal cap assays (Fig 4a, lanes 4–6) as observed
with our Super8XTOPFlash experiments (Fig. 3a). Injection of
xKaiso MO with a minimal amount of Wnt3a mRNA caused
up-regulation of siamois (Fig 4a, lanes 8 and 9) as reported previ-
ously [17]. These results indicate that both the loss-of-function and
gain-of-function of Kaiso can modulate siamois expression in vivo.
To monitor effects within the embryo, we injected xKaiso MO or
mRNA with b-catenin mRNA into the VMZ of the two blastomeres
at 4-cell stage. We observed xKaiso MO reduced axis duplication
Fig. 3. xKaiso mRNA synergized with Wnt3a (a) and Lef1 (b) in Super8XTOPFlash
luciferase reporter assay. mRNAs were injected into animal pole at both blastomere
of 2-cell stage embryos.
Fig. 4. Kaiso has bimodal effects on endogenous Wnt/b-catenin pathway. (a) xKaiso
synergized with Wnt3a. Three picograms of Wnt3a mRNA injection barely induced
siamois expression. When xKaiso mRNA was co-injected with Wnt3a, siamois
expression was upregulated (lanes 4, 5 and 6). Kaiso MO co-injection with Wnt3a
also increased siamois expression in animal caps (compare lane 7 with lanes 8 and
9). b) Kaiso knockdown reduced axis duplication induced by b-catenin. The xKaiso
MO was rescued by 3 or 6 pg of MO-resistant mRNA. Co-injection of Kaiso (3 or 6 pg
per embryo) and b-catenin increased double axis formation, but mild overexpres-
sion of Kaiso inhibits b-catenin activity.
Fig. 5. (a) Kaiso functions bimodally for Wnt/b-catenin signaling in 293T cells.
Super8XTOPFlash (50 ng) and RL-TK (5 ng) were cotransfected together with Kaiso
constructions (0.002, 0.01, 0.05, 0.25, 1.0 lg). Dominant-negative form of LEF1
(dnLEF1) was used as a negative control. Conditioned media were added in a 1:1
ratio to growth medium 12 h post-transfection. Luciferase activity was measured at
8 h after CM-exposure. (b) Kaiso blocks the interaction of b-catenin with HDAC1.
Plasmids encoding 6Myc-b-catenin SA (0.5 lg), HDAC1-FLAG (0.1 lg), and Kaiso
constructions (0.05, 0.25, 1.0 lg) were cotransfected for coimmunoprecipitation
assays. Axin-FLAG (0.25 lg) was used as a positive control.
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tively regulate the b-catenin pathway activity in vivo. This effect
was rescued by 3 or 6 pg of MO-resistant Kaiso mRNA injection
(Fig. 4b). However, an injection of 12 pg or higher of xKaiso mRNA
decreased the induction of the secondary axes. xKaiso mRNA injec-
tion at 3 and 6 pg per embryo had an additive effect with b-catenin.
Again, 12 pg or more xKaiso mRNA injection caused mild inhibition
of b-catenin signaling in axis duplication assay. These in vivo data
therefore suggest that Kaiso has bimodal activity for b-catenin sig-
naling. We further examined Kaiso function in mammalian 293T
cell using Super8XTOPFlash assays. While reporter activity was re-
pressed by high amount of Kaiso cDNA transfection (Fig. 5a, lane
14), mild overexpression of Kaiso with Wnt3a CM treatment had
additive effects on reporter activity (Fig. 5a, lanes 12 and 13). This
data indicates that bimodal activity of Kaiso in Wnt/b-catenin sig-
naling is not limited to Xenopus embryos.
3.5. Kaiso inhibits the interaction of b-catenin with histonedeacetylase
HDAC1
In the absence of Wnt stimulation, repressor Groucho/TLE binds
to TCF/LEF1 [11], whose inhibitory effect was mediated by the
interaction of HDAC1 [31]. Indeed it has been shown that HDAC1
is an inhibitory factor of Wnt/b-catenin signaling and forms a
complex with LEF1 and b-catenin [32]. To delineate a molecular
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ing, we performed coimmunoprecipitation assay of HDAC1 and
LEF1 or b-catenin with dose dependent Kaiso expression. When
cotransfected a stabilized form of b-catenin and HDAC1 with Kaiso
in 293T cells, less b-catenin protein was co-immunoprecipitated
with HDAC1 in a Kaiso-dependent manner, suggesting that Kaiso
blocked the association between b-catenin and HDAC1 (Fig. 5b).
We also observed that Kaiso overexpression reduced protein levels
of b-catenin and HDAC1 (Fig. 5b, lanes 5 and 6) likely caused by the
general repressor activity of Kaiso. These results imply Kaiso may
release b-catenin from the HDAC1-complex, resulting in more
b-catenin that is available for TCF/LEF1-complexes.4. Discussion
In this study, we demonstrate that Kaiso has bimodal activity in
Wnt/b-catenin signaling. Using a loss-of-function approach with
an xKaiso morpholino, b-catenin signaling was dramatically
reduced as demonstrated by the reporter activity read-out. We
observed that mild overexpression of Kaiso enhanced the signaling,
whereas higher levels of Kaiso expression inhibited b-catenin
signaling in vivo. Our co-injection results of xKaiso MO plus Lef1
mRNA or xKaiso mRNA with DN-TCF3 further suggesting that
Kaiso functions at the level of the transcription factor TCF/LEF1.
In addition, we showed that complex formation between b-catenin
and HDAC1 was blocked by Kaiso overexpression, implying a shift
in the balance towards greater availability of b-catenin for TCF/
LEF1.
Our Kaiso knockdown results using the reporter assays are
somewhat contradictory to previous studies that showed Kaiso
can negatively regulate siamois expression by repressing TCF/
LEF1 activity [17,19], even though we employed the identical MO
sequence and reporter construct for the siamois promoter. We be-
lieve this discrepancy may be due to where and how much of the
reporter constructs were injected. While Park et al. injected
0.5 ng of reporter constructs per embryo into one- or two-cell stage
embryos, we speciﬁcally injected only 20 pg of reporter constructs
into DMZ or VMZ together with xKaiso MO, where the endogenous
Wnt/b-catenin signaling is high and detectable. Alternatively, we
injected reporter constructs into the animal pole region with posi-
tive regulators of the Wnt/b-catenin pathway where the endoge-
nous Wnt/b-catenin signaling is very low. Though we observed
kinked embryos and apoptotic phenotypes in xKaiso morphants
as previously shown [22,23], we did not observe defects of dorsal
axis formation when xKaiso MO was injected into DMZ (data not
shown). As the Kaiso protein is present maternally [22,23] and a
MO only inhibits protein translation, it is possible that the levels
of maternal Kaiso protein may mask the effects of the xKaiso MO.
It is curious that Kaiso knockdown caused an opposite effect on
the luciferase reporter assay and endogenous expression level of
siamois, while small doses of ectopic expression of Kaiso in animal
caps increased siamois expression when co-injected with Wnt3a,
complementing the reporter assay data. It is plausible that a chro-
matin-based structure might lessen the requirement of Kaiso for
siamois transcriptional activity. Alternatively, Kaiso might regulate
siamois expression negatively through a more upstream or down-
stream region than that used in the siamois-luc construct. As
shown in Fig. 4, a minor overexpression of Kaiso mRNA (3 or
6 pg per embryo) has a positive role in induction of siamois expres-
sion and axis duplication assay, whereas even very mild overex-
pression of Kaiso mRNA (12 pg or higher per embryo) can
perturb Wnt/b-catenin signaling. This result implies that the
endogenous levels of Kaiso must be tightly regulated.
Our studies demonstrating Kaiso’s positive role in Wnt/b-cate-
nin pathway can partly explain the phenotype of the Kaiso nullmice on the ApcMin/+ background. Kaiso/y ApcMin/+ mice show less
tumor formation than Kaiso+/y ApcMin/+. It is possible that Kaiso-tar-
get genes may only partially overlap with TCF regulated genes and
Wnt/b-catenin responsive gene in the intestine might be less acti-
vated when Kaiso is targeted, thus Kaiso/y ApcMin/+ demonstrate
less intestinal cancer.
Although it was shown that Kaiso and d-catenin positively reg-
ulate rapsyn expression [9] which suggests that Kaiso has dual
activity in transcriptional regulation, it remains unclear how Kaiso
functions as a positive modulator in Wnt/b-catenin pathway. It is
plausible that Kaiso may inhibit the expression of repressors that
interact with TCF/LEF such as CtBP or Groucho. Alternatively, Kaiso
or Kaiso-interacting proteins may affect complex formation with
TCF/LEF1. Indeed, we observed that Kaiso reduced the interaction
of b-catenin with HDAC1 (Fig. 5b). When b-catenin, HDAC1 and
LEF1 were co-expressed, b-catenin preferably associated with
HDAC1 to Lef1 [32]. Our binding studies further suggest that Kaiso
inhibited HDAC1 association with b-catenin thereby increasing the
availability of b-catenin for TCF/LEF1-interaction. How Kaiso may
affect HDAC1 or possibly HDAC3 activity remains a central ques-
tion to be addressed, since it has been recently showed that N-
CoR and SMRT directly binds to b-catenin as well as TCF4 for atten-
uation of Wnt/b-catenin signaling [33]. Interestingly, this complex
was observed to contain HDAC3 instead of HDAC1 [34]. Another
recent study showed the methylated-DNA binding proteins,
MeCP2, functioned not only as transcriptional a repressor but also
as an activator by recruiting by CREB1 [35], suggesting such a bi-
modal function may not be limited to Kaiso. Thus, it is of interest
to ascertain whether Kaiso is also capable of associating with co-
activator complexes.
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